Perfil de la empresa · Healthcare

Zimmer Biomet Holdings Inc

ZBH · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
25 de julio de 2001
Empleados
17.000
Precio actual
$87.97
En vivo · 18 de junio de 2026
Compra razonable
≤ $75
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
40/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $87.97 En vivo · Entre el rango conservador y el razonable

Rango de valoración compuesto · conservador $70–$80 / razonable $95–$110 / optimista $125–$145. A $87.97, Entre el rango conservador y el razonable.

Al publicar $82.33 (30 de mayo de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Capitalización17,19 mil MUS$
Ingresos (TTM)8409,1 MUS$
EBITDA2581 MUS$
Margen neto9,05 %
ROE6,07 %
PER (TTM)23,02
PER previsto10,7
PEG0,63
BPA3,86 US$
Rentabilidad por dividendo1,07 %
Rango de 52 semanas79,12 US$ – 107,45 US$
Precio objetivo de analistas98,70 US$
Recomendación de analistas3.4 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.